• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » inVentive Health names president for Europe and executive VP for Asia

inVentive Health names president for Europe and executive VP for Asia

October 1, 2013
CenterWatch Staff

Global CRO inVentiv Health has created two new positions to lead its business in Europe and Asia.

Dan Feldman, who established and led inVentiv’s operation in Japan, will take on the new position of president of inVentiv Health Europe. The position will oversee the growth of business across all inVentiv Health segments—clinical research, commercialization and consulting—and will lead development of inVentiv’s approach to convergent services. 

Stephen J. Walter will join the company as executive vice president for Asia. Walter formerly was managing director for Merck Sharpe & Dhome in Vietnam and Cambodia. Previously, he worked as general manager and vice president of consulting and services for IMS Health, based in Singapore. For Bristol-Myers Squibb, he helped launch Entecavir in the Asia Pacific region and was then regional director of business development.

Walter will oversee growth and management of all inVentiv Health business throughout the region, including the expansion of inVentiv’s clinical research capabilities in China. 

Walter, who will be based in Shanghai, will oversee inVentiv operations in the ASEAN nations, Australia and New Zealand, in addition to China and Korea.  He also will assume responsibility for Japan at the end of this year, when he takes the reins from Feldman.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing